|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
MVista® Coccidioides Antigen Quantitative EIA
Test Code19448
CPT Codes
87449<br><strong>This test code is for non-New York patient testing. For New York patient testing, refer to test code 93348.</strong>
Preferred Specimen
1.2 mL plasma collected in a sodium heparin (green-top) or sodium citrate (light blue-top) tube OR other body fluids collected in a sterile leak-proof container
Minimum Volume
0.8 mL
Instructions
Plasma: Centrifuge for 15 minutes and pipette into a transport tube.
Note: Ship next day service Monday-Friday delivery.
Limitations:
The result is not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Cross reactions are seen with histoplasmosis, blastomycosis and paracoccidioidomycosis. Sputolysin, sodium hydroxide, and potassium hydroxide treatment degrade the analyte detected in the assay.
Low positive cross-reactions can occur in patient populations with rheumatoid arthritis.
Note: Ship next day service Monday-Friday delivery.
Limitations:
The result is not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Cross reactions are seen with histoplasmosis, blastomycosis and paracoccidioidomycosis. Sputolysin, sodium hydroxide, and potassium hydroxide treatment degrade the analyte detected in the assay.
Low positive cross-reactions can occur in patient populations with rheumatoid arthritis.
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 28 days
Refrigerated: 28 days
Frozen: 60 days
Refrigerated: 28 days
Frozen: 60 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Samples in transport media, fixative or isolator tubes • Non-pipettable specimens • Tissue • Biopsy • Sputum • Bronchial brush • Tracheal aspirate • FNA • Bone marrow • Aspirate or stool
Methodology
Quantitative Sandwich Enzyme Immunoassay
FDA Status
This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Setup Schedule
Set up: Mon-Fri; Report available: 1-2 days
Reference Range
See Laboratory Report

